{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:04:41Z","timestamp":1787015081474,"version":"build-2736575974"},"reference-count":27,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1538,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1742-1241.2011.02682.x","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T02:43:02Z","timestamp":1308278582000},"page":"896-902","source":"Crossref","is-referenced-by-count":34,"title":["Acromegaly: presentation, morbidity and treatment outcomes at a single centre"],"prefix":"10.1155","volume":"65","author":[{"given":"P.","family":"Anagnostis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. A","family":"Efstathiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Adamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Slavakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sapranidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. D","family":"Litsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Katergari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Selalmatzidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,16]]},"reference":[{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/BF03349263","article-title":"Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults","volume":"31","author":"Giustina","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1009965803750","article-title":"Epidemiology of acromegaly","volume":"2","author":"Holdaway","year":"1999","journal-title":"Pituitary"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a meta-analysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","article-title":"Guidelines for acromegaly management: an update","volume":"94","author":"Melmed","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","article-title":"A consensus on criteria for cure of acromegaly","volume":"95","author":"Giustina","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1210\/jc.85.2.526","article-title":"Criteria for cure of acromegaly: a consensus statement","volume":"85","author":"Giustina","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-07-0358","article-title":"AcroBel-the Belgian registry on acromegaly: a survey of the \u2018real-life\u2019 outcome in 418 acromegalic subjects","volume":"157","author":"Bex","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","article-title":"Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA)","volume":"151","author":"Mestron","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2003-031584","article-title":"Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly","volume":"89","author":"Ayuk","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1210\/jc.86.9.4072","article-title":"Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria","volume":"86","author":"Kreutzer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2265.2003.01679.x","article-title":"Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly","volume":"58","author":"Beauregard","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/eje.1.01863","article-title":"The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical \u2018cure\u2019","volume":"152","author":"Nomikos","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1210\/jc.85.12.4596","article-title":"Ten-year follow-up results of transsphenoidal microsurgery in acromegaly","volume":"85","author":"Biermasz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1210\/jc.83.10.3411","article-title":"Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results","volume":"83","author":"Abosch","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1210\/jc.2002-021822","article-title":"Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission","volume":"88","author":"De","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0889-8529(18)30208-1","article-title":"Surgical management of acromegaly","volume":"21","author":"Fahlbusch","year":"1992","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MED.0b013e32833abcba","article-title":"The role of outcomes data for assessing the expertise of a pituitary surgeon","volume":"17","author":"Shahlaie","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/jc.2005-1208","article-title":"Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly","volume":"91","author":"Colao","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2265.2003.01734.x","article-title":"Primary medical therapy for acromegaly","volume":"58","author":"Sheppard","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2265.2008.03441.x","article-title":"Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study","volume":"70","author":"Colao","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1210\/jc.83.9.3034","article-title":"Octreotide as primary therapy for acromegaly","volume":"83","author":"Newman","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/BF03346419","article-title":"Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients","volume":"31","author":"Attanasio","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF03345491","article-title":"Effects of two different somatostatin analogs on glucose tolerance in acromegaly","volume":"25","author":"Ronchi","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00701-004-0466-2","article-title":"Treatment outcomes and mortality of 94 patients with acromegaly","volume":"147","author":"Trepp","year":"2005","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1111\/j.1742-1241.2011.02682.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2265.2008.03181.x","article-title":"Amelioration of cardiovascular risk factors with partial biochemical control of acromegaly","volume":"69","author":"Delaroudis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2011.02682.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2011.02682.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T01:07:55Z","timestamp":1643332075000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2011.02682.x"}},"subtitle":["Acromegaly: a single centre experience"],"short-title":[],"issued":{"date-parts":[[2011,6,16]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02682.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,16]]}}}